Adam Chazan joined Cowen as a managing director in the investment banking division, responsible for the firm’s tools and diagnostics banking practice.
Chazan will be based in New York and will report to George Milstein, head of Cowen’s healthcare investment banking group.
“We are excited to have Adam join our team, adding to Cowen’s leading healthcare investment banking franchise,” Larry Wieseneck, co-president of Cowen, said. “Over the last several years, Cowen has solidified its position as a leader across the healthcare landscape where novel tools, technologies and healthcare converge. Adam’s deep expertise, network and leadership skills make him the perfect partner to help us accelerate our leading position in the future of healthcare solutions.”
“Cowen’s position supporting and partnering with the entrepreneurs and companies changing the face of healthcare is well established. I look forward to working with the Cowen team to provide world class advice and execution to a fast-growing list of disruptive companies,” Chazan said.
“I have known Adam as both a friend and a colleague for many years. It is the perfect time for him to be joining Cowen given the significant momentum in our future health practice. With Adam’s leadership we are well positioned to support clients through the continued evolution of healthcare,” Milstein said.
Prior to joining Cowen, Chazan served at Bank of America for 10 years, most recently as the global co-head of medical technology investment banking. Prior to Bank of America, Chazan held positions at Leerink Swan, Merril Lynch, Pacific Growth Equities, ING and William Blair.
Cowen is a diversified financial services firm operating through two business segments: a broker dealer and an investment management division.
